Concomitant Human Herpes Virus 6 and nivolumab-related pneumonitis: Potential pathogenetic insights

The development of immune system modulating agents, such as immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment. Nivolumab, a human monoclonal antibody against PD-1, has emerged as an efficient treatment for various malignancies, including non-small cell lung cancer (NSCLC); how...

Descripción completa

Detalles Bibliográficos
Autores principales: Foukas, Periklis G., Tsiodras, Sotirios, Economopoulou, Panagiota, Spathis, Aris, Mademli, Maria, Leventakos, Konstantinos, Psyrri, Amanda, Karakitsos, Petros, Panayiotides, Ioannis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852387/
https://www.ncbi.nlm.nih.gov/pubmed/29552493
http://dx.doi.org/10.1016/j.idcr.2018.01.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852387/
https://www.ncbi.nlm.nih.gov/pubmed/29552493
http://dx.doi.org/10.1016/j.idcr.2018.01.013

Ejemplares similares